# Safety and Feasibility Study of Autologous Stromal Vascular Fraction (SVF) Cells for Treatment of Osteoarthritis

> **NCT01885832** · PHASE1,PHASE2 · WITHDRAWN · sponsor: **Translational Biosciences**

## Conditions studied

- Osteoarthritis

## Interventions

- **BIOLOGICAL:** Autologous adipose tissue stromal vascular fraction

## Key facts

- **NCT ID:** NCT01885832
- **Lead sponsor:** Translational Biosciences
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2013-06
- **Primary completion:** 2016-07
- **Final completion:** 2016-12
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** per sponsor decision
- **Last updated:** 2017-08-10


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01885832

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01885832, "Safety and Feasibility Study of Autologous Stromal Vascular Fraction (SVF) Cells for Treatment of Osteoarthritis". Retrieved via AI Analytics 2026-06-26 from https://api.ai-analytics.org/clinical/NCT01885832. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*